Flinton Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $3.13M | Buy |
42,738
+5,610
| +15% | +$411K | 0.1% | 170 |
|
|
2019
Q2 | $2.29M | Buy |
37,128
+5,610
| +18% | +$345K | 0.07% | 206 |
|
|
2019
Q1 | $2.01M | Buy |
31,518
+4,080
| +15% | +$260K | 0.07% | 214 |
|
|
2018
Q4 | $1.4M | Buy |
27,438
+2,856
| +12% | +$146K | 0.05% | 234 |
|
|
2018
Q3 | $1.43M | Sell |
24,582
-306
| -1% | -$17.8K | 0.04% | 259 |
|
|
2018
Q2 | $1.21M | Buy |
24,888
+1,428
| +6% | +$69.3K | 0.04% | 281 |
|
|
2018
Q1 | $1.09M | Sell |
23,460
-2,040
| -8% | -$94.9K | 0.04% | 273 |
|
|
2017
Q4 | $958K | Buy |
25,500
+5,916
| +30% | +$222K | 0.03% | 293 |
|
|
2017
Q3 | $714K | Sell |
19,584
-10,506
| -35% | -$383K | 0.03% | 324 |
|
|
2017
Q2 | $1.19M | Sell |
30,090
-16,014
| -35% | -$631K | 0.04% | 249 |
|
|
2017
Q1 | $1.45M | Sell |
46,104
-93,126
| -67% | -$2.92M | 0.06% | 221 |
|
|
2016
Q4 | $4.35M | Buy |
+139,230
| New | +$4.35M | 0.19% | 104 |
|